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In skeletal muscle, asymmetrically dividing satellite
stem cells give rise to committed satellite cells that
transcribe the myogenic determination factor Myf5,
a Pax7-target gene. We identified the arginine meth-
yltransferase Carm1 as a Pax7 interacting protein
and found that Carm1 specifically methylates mul-
tiple arginines in the N terminus of Pax7. Methylated
Pax7 directly binds the C-terminal cleavage forms
of the trithorax proteins MLL1/2 resulting in the
recruitment of the ASH2L:MLL1/2:WDR5:RBBP5 his-
tone H3K4 methyltransferase complex to regulatory
enhancers and the proximal promoter of Myf5.
Finally, Carm1 is required for the induction of de
novo Myf5 transcription following asymmetric satel-
lite stem cell divisions. We defined the C-terminal
MLL region as a reader domain for the recognition
of arginine methylated proteins such as Pax7. Thus,
arginine methylation of Pax7 by Carm1 functions
as a molecular switch controlling the epigenetic
induction of Myf5 during satellite stem cell asym-
metric division and entry into the myogenic program.
INTRODUCTION
Satellite cells located beneath the basal lamina of myofibers
are required for the growth and regeneration of skeletal muscle
(Bishcoff, 1994; Charge´ and Rudnicki, 2004). A small subset of
the satellite cell population are stem cells that are capable of re-
constituting the satellite cell population following transplanta-
tion, and give rise to committed myogenic progenitors through
asymmetric apical-basal cell divisions (Collins et al., 2005; Mon-
tarras et al., 2005; Kuang et al., 2007). Satellite stem cells resist
differentiation, are capable of long-term self-renewal, and exten-
sively contribute to the satellite cell reservoir upon transplanta-
tion (Kuang et al., 2007).
Cre-LoxP lineage tracing using Myf5-Cre and R26R-eYFP
alleles allows the discrimination between committed satellite
myogenic cells that have expressedMyf5-Cre (YFP+) and a smallCell Ssubpopulation (<10%) of satellite stem cells that have never ex-
pressedMyf5-Cre (YFP) (Kuang et al., 2007). Satellite stem cells
express Tie-2, and Angiotensin-1 signaling from fibroblasts and
vascular cells stimulates ERK activation to increase the number
of quiescent satellite cells (Abou-Khalil et al., 2009). Satellite
stem cells also express high levels of Fzd7 and signaling through
theWnt7a/Fzd7 planar-cell-polarity pathway drives the symmet-
ric expansion satellite stem cell division to accelerate and aug-
ment muscle regeneration (Le Grand et al., 2009). Thus the iden-
tification of satellite stem cells has facilitated important insights
into satellite cell biology.
Myf5 is a member of the MyoD-family of basic helix-loop-helix
(bHLH) transcription factors that play essential roles in regulating
the developmental program of skeletal muscle (Charge´ and
Rudnicki, 2004). Myf5 together with MyoD are required to en-
force myogenic identity (Rudnicki et al., 1993; Kassar-Duchos-
soy et al., 2004). Myf5 is a direct target of the paired-box tran-
scription factors Pax3 and Pax7 (Bajard et al., 2006; McKinnell
et al., 2008). Therefore, the transcriptional activation of Myf5 by
Pax7 in a satellite myogenic cell following an asymmetric satellite
stem cell division demarcates myogenic commitment.
Pax7 is expressed at high levels in all satellite cells and plays
an essential role in regulating their function. Pax3 is expressed
in satellite cells in a subset of muscles such as the diaphragm,
but satellite cells in most muscle groups express very low levels
of Pax3 (Kassar-Duchossoy et al., 2005). Pax7-deficient satellite
cells are progressively lost in all muscle groups due to survival
deficits or precocious differentiation (Kuang et al., 2006; Ousta-
nina et al., 2004; Relaix et al., 2006; Seale et al., 2000). Notably,
the musculature in Pax7/mice is reduced in mass, the myofib-
ers contain50% the normal number of nuclei, and fiber calibers
are significantly reduced (Kuang et al., 2006). However, this
requirement for Pax7 in satellite cells has been suggested to
be limited to a critical juvenile period when satellite cells are tran-
sitioning to a quiescent state (Lepper et al., 2009).
Pax7 activates target genes through recruitment of a histone
methyltransferase (HMT) trithorax complex (McKinnell et al.,
2008). Mass spectrometry of proteins that were copurified
with Pax7 revealed association with the ASH2L:MLL1/2:WDR5:
RBBP5 (HMT) complex that directs methylation of histone H3
lysine 4 (H3K4). Pax7 specifically binds and recruits this HMT
complex to regulatory sites of its target genes, resulting in
H3K4 trimethylation of surrounding chromatin and the proximaltem Cell 11, 333–345, September 7, 2012 ª2012 Elsevier Inc. 333
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satellite myogenic cells express Pax7. Therefore, the absence
of Myf5 transcription in satellite stem cells suggests that the
ability of Pax7 to activateMyf5 transcription is subject to regula-
tion during satellite stem cell asymmetric cell division.
Trimethylation of histone H3K4 is highly correlated with
transcriptionally active genes (Ruthenburg et al., 2007), and the
MLL1/2 trithorax complex is required for the epigenetic ac-
tivation multiple gene programs including Hox and neuronal
genes during development (Guenther et al., 2005; Lim et al.,
2009). MLL forms a multiprotein complex composed of ASH2L,
WDR5, RBBP5, and Dyp30, and the carboxyl-terminal SET
domain of MLL1/2 contains the enzymatic histone methyltrans-
ferase domain (Schuettengruber et al., 2011). Recent studies re-
vealed that recruitment of theMLL1/2 complexes to target genes
is tightly regulated and can be mediated by either transcription
factors, long noncoding RNA or Wdr5 (Wysocka et al., 2005;
Bertani et al., 2011; Schuettengruber et al., 2011). However, a
detailed understanding of the mechanism regulating recruitment
of the HMT complexes remains unknown.
Carm1, also called PRMT4, is a protein arginine methyltrans-
ferase that methylates histone H3 on arginine 17 (R17) and 26
(R26) and has been implicated in various cellular processes
including signal transduction, mRNA splicing, and transcriptional
control (Chen et al., 1999; Ma et al., 2001; Bauer et al., 2002;
Bedford and Clarke, 2009). Carm1 methyltransferase activity is
not limited to histones but also include other proteins such as
transcriptional coactivators CBP and SRC-3, and transcription
factors C/EBPb and Sox2 (Xu et al., 2001; Feng et al., 2006;
Kowenz-Leutz et al., 2010; Zhao et al., 2011). Carm1 has previ-
ously been shown to positively regulate myogenic differentiation
through binding of Myogenin and Mef2c and subsequent argi-
nine methylation of histone H3 R17 in the regulatory regions
of target genes (Chen et al., 2002; Gao et al., 2010). Moreover,
in MyoD-overexpressing fibroblasts derived from Carm1-defi-
cient embryos, Carm1 facilitates interaction with the SWI/SNF
chromatin-remodeling enzyme and remodeling of gene loci ex-
pressed late during myogenic differentiation (Dacwag et al.,
2009).
In this study, we set out to investigate the mechanism that
regulates the activity of Pax7 during satellite stem cell asym-
metric cell division. We found that Pax7 is a specific substrate
of Carm1 and that Carm1 methylation of Pax7 is required for
MLL complex binding. Moreover, we found that Carm1 is re-
quired for Pax7 to epigenetically activate Myf5 transcription
following asymmetric satellite stem cell division. Lastly, we
have defined the C-terminal MLL region as a reader domain for
the recognition of arginine methylated proteins. Thus, Carm1
methylation of Pax7 functions as a molecular switch, controlling
the epigenetic induction of Myf5 transcription, to regulate satel-
lite stem cell entry into the myogenic program.
RESULTS
Carm1 Binds Pax7 to Regulate Myf5 Transcription
We identified Carm1/Prmt4 as a candidate Pax7 interacting pro-
tein following isolation of the Pax7 protein complex from primary
myoblasts by tandem affinity purification and tandem mass
spectrometry. The interaction between endogenous Pax7 and334 Cell Stem Cell 11, 333–345, September 7, 2012 ª2012 Elsevier ICarm1 was confirmed by coimmunoprecipitation analysis using
Carm1 antibody in primary myoblasts (Figure 1A).
To determine whether Carm1 interacts directly with Pax7,
we used purified recombinant, glutathione S-transferase (GST)
tagged Carm1 and 3xFLAG tagged Pax7 (Pax7-FLAG) ex-
pressed in Sf9 cells in a GST binding assay (Figure 1B; Figures
S1A and S1B available online). We observed that GST-Carm1,
but not GST alone, associated with Pax7-FLAG, demonstrating
a direct interaction between Pax7 and Carm1. We also found
that Carm1 binds Pax3 and Pax6 and confirmed the known inter-
action between Carm1 and Mef2c.
To identify the region of Pax7 that binds Carm1, we performed
an in vitro binding experiment between a deletion series of Pax7-
FLAG proteins and GST-Carm1. Notably, the N-terminal region
of Pax7, containing the paired domain, was sufficient to bind
Carm1 (Figure 1C). Therefore, these data suggest that the
interaction with Carm1 is conserved among paired box domain
proteins.
To investigate whether Carm1 has a role in regulating Pax7
activity, we assessed the expression level of Myf5 follow-
ing transfection of Carm1 siRNA into primary myoblasts and
confirmed the knockdown by qRT-PCR and western blot
(Figures 1D and S1C). Strikingly, depletion of Carm1 with siRNA
resulted in a marked decrease in expression of Myf5 mRNA
(Figure 1D). Carm1 knockout (Carm1/) primary myoblasts
generated from tamoxifen-treated Pax7-CreERT2:Carm1flox/flox
mice also displayed reduced levels of Myf5 expression relative
to cells infected with retrovirus expressing wild-type (WT)
Carm1 (Figures 1E and S1D, see Experimental Procedures).
By contrast, infection with retrovirus expressing a catalytic
mutant (E267Q) of Carm1 did not restore Myf5 mRNA levels
(Figure 1E) (Lee et al., 2002). Ectopic expression of Carm1 WT
in Carm1/ primary myoblasts restored arginine methyla-
tion as detected by anti-histone H3 asymmetric dimethyl R17
(aH3R17me2a) antibody, but not in mock or Carm1 E267Q
mutant infected Carm1/ primary myoblasts (Figure S1D) (Ya-
dav et al., 2003).
Overexpression of Pax7 in primary myoblasts results in upre-
gulation of Myf5 mRNA level (McKinnell et al., 2008). However,
we found that overexpression of Pax7 in Carm1-deficient pri-
mary myoblasts was unable to induce Myf5 upregulation, while
simultaneous ectopic expression of Carm1 WT rescued Myf5
induction (see below). Taken together, these results are consis-
tent with the hypothesis that Carm1 regulates the ability of Pax7
to activate Myf5 transcription.
Carm1 Specifically Methylates Pax7 in Amino Terminus
Domain
To evaluate the possibility of that Carm1 directly methylates
Pax7, we conducted an in vivo methylation assay using pri-
mary myoblasts ectopically expressing FLAG-tagged Pax7
(Pax7-FLAG) (Figure 2A). Ectopically expressed Pax7was immu-
noprecipitated by anti-FLAG antibody and de novo methylation
determined by autoradiography. At the same time, Prmt inhibi-
tors, 50-deoxy-50-(methylthio) adenosine (MTA) and adenosine-
20, 30-dialdehyde (Adox) were added into labelingmedia to inhibit
arginine methylation. Since methylation of Pax7 was not evident
in the presence of MTA/Adox, we conclude that Pax7 is methyl-
ated by an arginine methyltransferase in vivo.nc.
Figure 1. Carm1 Interacts with Pax7 and
Regulates Myf5 Expression
(A) Coimmunoprecipitation of endogenous Pax7
with Carm1 from primary myoblasts. Endogenous
Pax7 is detectable by immunoblotting when
Carm1-associated proteins are immunoprecipi-
tated with anti-Carm1 antibody from whole cell
extract (WCE).
(B) Interactions between Carm1 and indicated
FLAG tagged proteins were detected by in vitro
GST pull-down assays. Schematic representation
of mouse Pax7, Pax3, Pax6, and Mef2c were
shown in the left panel. Percentage identity
between the paired domain (PD) or homeo domain
(HD) of these proteins is indicated.
(C) Mapping of the Carm1-interacting domain of
Pax7 to the N-terminal region containing the
paired domain by in vitro binding (right). The left
panel shows the Pax7 deletion series. PD; paired
domain, OP; octa-peptide motif, HD; homeo box
domain; asterisk, nonspecific band.
(D) Depletion of Carm1 with siRNA results in
decreased expression ofMyf5. RT-qPCR analysis
from control (siCtrl) and Carm1 (siCarm1) siRNA
transfected primary myoblasts (n = 3, error bars
represent SEM).
(E) Catalytically active Carm1 rescues Myf5
expression levels in Carm1-deficient myoblasts.
RT-qPCR (right) analysis from mock, 6xMyc-
Carm1 WT, and E267Q mutant overexpressing
Carm1/ primary myoblasts (n = 3, error bars
represent SEM).
See also Figure S1.
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ascribable to Carm1, we performed the same in vivo methylation
assay using Cre-deleted Carm1 heterozygote (Carm1+/) and
Carm1/ primary myoblasts overexpressing Pax7-FLAG. Im-
portantly, our data demonstrated that Pax7 methylation is
Carm1-dependent (Figure 2B, see Experimental Procedure).
To extend this analysis, we performed in vitro methyltransfer-
ase assays for Pax7 using immunoprecipitated 6xMyc tagged
Prmts including Carm1, Carm1 E267Q mutant, Prmt1, Prmt5,
and Prmt6. The methyltransferase activity of the purified Prmts
was confirmed by histone methyltransferase assays (Figure S2).
Notably, this experiment demonstrated that only Carm1 is capa-
ble of methylating Pax7 (Figure 2C).
To understand the Carm1 substrate specificity, we applied
an in vitro methylation assay using Carm1 binding proteins,
including Pax7, Pax3, Pax6, and Mef2c shown in Figure 1B as
substrates (Figure 2D). Interestingly, unlike the in vitro binding
assay, specific methylation was detected using Pax7 and Pax3
as substrates, but not Pax6 and Mef2c. Therefore, Pax7 and
Pax3 are specific substrates of Carm1, and interacting proteins
are not necessarily always a substrate.
Although other Prmts are known to methylate arginine resi-
dues within glycine-arginine-rich motifs (GAR), the consensus
sequence for Carm1methylation has not been fully defined (Bed-
ford and Clarke, 2009). To identify the arginines in Pax7 that are
methylated by Carm1, we first performed in vitro methylationCell Sassays using the deletion series of Pax7 (Figure 2E). Significant
methylation was detected in the N-terminal 1–37 aa of Pax7,
with weaker methylation in the paired domain. Methylation was
also detected in N-terminal 1–37 aa of Pax3, suggesting the
N-terminal 37 aa of both Pax7 and Pax3, contain arginine resi-
dues that are methylated by Carm1 (Figure 2F).
Examination of the N-terminal region among mouse paired-
box transcription factors revealed a highly conserved region in
Pax7 and Pax3 containing four arginine residues at positions
10, 13, 22, and 37 (Figure S3A). The region also contained a
proline-glycine-methionine (PGM) motif, which has been noted
inCarm1 substrates alongwith the arginine residues (Figure S3B)
(Bauer et al., 2002; Lee and Bedford, 2002; Bedford and Clarke,
2009; Sims et al., 2011). These arginine residues and PGMmotifs
are well conserved across vertebrate Pax7 and Pax3 proteins
(Figure 3A). Liquid chromatography-tandem mass spectrometry
analysis of immunoprecipitated Pax7-FLAG protein from Pax7-
FLAG overexpressing primary myoblasts confirmed Arg10, 13,
22, and 37 as sites of methylation within the N-terminal domain
and identified an additional ten arginines that are also methyl-
ated (Figures 3B, S3C, and S3D and Table S1).
To assess the biological significance of this methylation,
we substituted arginine residues R10, R13, R22, and R37 with
lysine by site directed mutagenesis and performed in vitro
methylation assays. When all four arginines were mutated in
Pax7, we found a marked decrease in the level of methylationtem Cell 11, 333–345, September 7, 2012 ª2012 Elsevier Inc. 335
Figure 2. Carm1 Specifically Methylates Pax7
(A) Autoradiography and western blot analysis of immunoprecipitated Pax7-FLAG from in vivo [3H]-methionine labeled primary myoblasts cultured in the
presence or absence of Carm1 inhibitor MTA/Adox. [3H]-labeled methylation of Pax7 was detected by autoradiography (top).
(B) Autoradiography and western blot analysis of immunoprecipitated Pax7-FLAG antibody from in vivo [3H]-methionine labeled Carm1-deficient primary
myoblasts.
(C) Autoradiography of in vitro methylation assay of recombinant Pax7 with immunoprecipitated 6xMyc-Prmts.
(D) Autoradiography and protein staining of in vitro methylation assay for FLAG-tagged recombinant proteins with GST-Carm1.
(E) Domain mapping of the Pax7 region methylated by Carm1. C-terminal FLAG tagged Pax7 deletion constructs (left) were ectopically expressed in HEK293T
cells and purified by anti-FLAG M2 agarose. Methylation of these constructs was analyzed using an in vitro methylation assay with purified GST-Carm1 and
S-adenocyl [3H]-AdoMet and subsequently detected by autoradiography (right bottom). FLAG tagged Pax7 deletion mutants were detected by western blot
analysis using anti-FLAG antibody (right top). Relative intensity methylation for Pax7 deletion mutants are indicated by + or  (+++ > ±).
(F) In vitro methylation assay for N-terminal 37 aa deleted Pax7, Pax3, and Pax6. C-terminal FLAG tagged Pax7, Pax3, and Pax6 constructs (left) were ectopically
expressed in HEK293T cells and purified by anti-FLAGM2 agarose. Methylation of these proteins was analyzed by in vitro methylation assay using purified GST-
Carm1 and detected by autoradiography (bottom right). FLAG tagged proteins were detected by western blot analysis using anti-FLAG antibody (top right).
See also Figure S2.
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result was observed following in vitro methylation using Pax7-
Pax6 chimeric protein containing 1–37 aa from Pax7 4RK fused
with Pax6 (Figure S3G). Importantly, in vivo methylation was
markedly decreased in Pax7 4RK mutant when overexpressed
in primary myoblasts (Figures 3C and S3F). Finally, overexpres-
sion of the Pax7 4RK mutant was unable to induce Myf5 tran-
scription in the samemanner as Pax7WT (Figure 3D). Therefore,
we conclude that R10, R13, R22, and R37 represent the major
sites of methylation in Pax7 and are required for Pax7 function
in vitro and in vivo.336 Cell Stem Cell 11, 333–345, September 7, 2012 ª2012 Elsevier ICarm1Methylation of Pax7DoesNot Affect DNABinding
Activity
To assess whether Carm1 directed methylation of Pax7 effects
DNA binding, we performed electrophoretic mobility shift assays
(EMSA). WT and 4RK mutant of Pax7-FLAG proteins were puri-
fied from E. coli and thus are not methylated on arginine resi-
dues. We then performed EMSA experiments using in vitro
methylated or unmethylated Pax7 WT or 4RK mutant on Pax3/
7 binding element from the Myf5 -57.5 kb regulatory element
(Figures S4A–S4C) (Bajard et al., 2006; McKinnell et al., 2008).
Remarkably, EMSA experiments indicated that the DNA bindingnc.
Figure 3. Methylation of Pax7 by Carm1 within the N-Terminal PGM
Motif Is Required for Myf5 Induction
(A) Amino acid sequence alignment of N-terminal 37 aa in Pax7 and Pax3
among the indicated species. Conserved arginine residues in Pax7 and Pax3
are highlighted in black and proline glycine methionine rich (PGM) motifs are
highlighted in gray.
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Cell Sactivity of Pax7 WT and 4RK mutant was unaffected by methyl-
ation (Figures S4D and S4E).
In addition, a one-hybrid experiment was performed by
cotransfection of a C-terminal VP16 fused Pax7 WT or 4RK
mutant with a luciferase reporter plasmid carrying the same
DNA sequence as the EMSA experiment in C3H10T1/2 cells.
These experiments indicated that the 4RK mutant exhibited
unaltered activity (Figure S4F). These data demonstrate that
DNA-binding by Pax7 is unaffected by Carm1 methylation
and suggest the possibility that Pax7 cofactor recruitment is
affected.
Carm1 Methylation of Pax7 Regulates Binding
of MLL1/2
Pax7 recruits the ASH2L:WDR5:MLL1/2:RBBP5 histone methyl-
transferase (HMT) complex to regulatory elements on target
genes such as Myf5 to activate transcription (McKinnell et al.,
2008). Therefore, we investigated whether arginine methylation
of Pax7 by Carm1 regulates recruitment of the HMT complex.
The binding of methylated Pax7 to individual complex compo-
nents was assessed by in vitro pull-down assays using methyl-
ated or unmethylated Pax7, with nuclear extracts, and the inter-
actions were assessed by western blot analysis using specific
antibodies against the components of the HMT complex. Strik-
ingly, we observed that methylated Pax7, but not unmethylated
Pax7, bound the HMT complex (Figure 4A).
To identify which of the complex components was directly in-
teracting with methylated Pax7, we performed the in vitro bind-
ing assay using methylated Pax7 and in vitro translated com-
plex core components: C-terminal cleavage forms of MLL1/2;
MLL1(c) and MLL2/TRX2(c);and ASH2L, RBBP5, and Wdr5 (Ca-
potosti et al., 2007). We observed methylation-dependent inter-
action only with the catalytic core component, MLL1(c) and
MLL2(c), but not with any other components. Similarly, this inter-
action was noted with methylated Pax3, but not with Pax6 (Fig-
ure 4B). Moreover, methylation at R10, R13, R22, and R37 of
Pax7 was required for this interaction, as the Pax7 4RK mutant
did not bind MLL1/2 in the in vitro binding assay (Figures 4C
and S3F).
To establish that the interaction between MLL1/2 and Pax7
is regulated byCarm1 in vivo, we performed a three-hybrid assay
where Pax7-FLAG (WT or 4RK), VP16-MLL1(c) or VP16-MLL2(c),
and 6Myc-Carm1 (WT or E267Q mutant) expression vectors
using the Myf5 -57.5 kb luciferase reporter were cotransfected
into Cre-deleted Carm1/ primary myoblasts (Figure 4D). Our
results demonstrate that Carm1 methylates Pax7 to regulate
the recruitment of the MLL complex to Pax7 bound regulatory
sequences such as Myf5 gene through direct binding to the
C-terminal forms of MLL1 and MLL2.(B) Methylated arginines in Pax7were identified by in vitromethylation assay or
LC-MS/MS (lower). The PGM motif is highlighted in gray (proline, glycine and
methionine) and arginine is highlighted in black.
(C) Autoradiography and western blot of immunoprecipitated Pax7-FLAG WT
and 4RK mutant from in vivo [3H]-methionine labeled primary myoblasts.
(D) RT-qPCR and Western blot of primary myoblasts overexpressing Pax7-
FLAG series of arginine mutants. RelativeMyf5mRNA induction is normalized
to the amount of Pax7mRNA in each cell line (n = 3, error bars represent SEM).
See also Figure S3.
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Figure 4. Direct Interaction between Arginine Methylated Pax7 and MLL1/2
(A) Methylated Pax7 interacts with the MLL complex. In vitro binding assays were performed using in vitro methylated Pax7 and nuclear extract from primary
myoblasts.
(B) In vitro binding assay using in vitro methylated Pax7, Pax3, or Pax6 and in vitro translated 6xMyc-MLL1(c), MLL2(c), Wdr5, ASH2L, or RBBP5.
(C) N-terminal Pax7 arginine methylation is required for interaction with MLL2. In vitro binding assays were performed using methylated Pax7 and in vitro
translated 6xMyc-MLL2(c).
Interactions described in (A)–(C) were detected by western blot analysis.
(D) Pax7 andMLL1 or MLL2 interactions require Carm1. A three hybrid assay was performed by transfecting combinations of plasmids expressing Pax7 or Pax7-
4RK mutant, VP16-MLL1(c) or VP16-MLL2(c), or 6xMyc-Carm1 WT or E267Q mutant with luciferase reporter plasmid containing Myf5 -57.5 kb promoter and
renilla internal control reporter plasmid DNA into Carm1-deficient primary myoblasts. The interactions were detected as the relative luciferase activity compared
to mock transfected control (n = 3, error bars represent SEM).
(E) In vitro binding assay between proteins with Carm1 arginine methylated PGM motifs and in vitro translated 6xMyc-MLL2(c).
See also Figure S4.
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domains can specifically recognize arginine methylated nonhis-
tone proteins. For example, the binding of the SMN Tudor
domain to arginine methylated CA150, and TDRD3 to arginine
methylated RNApolII CTD (Cheng et al., 2007; Coˆte´ and Richard,
2005; Sims et al., 2011). Moreover, TDRD3 contains a reader
domain that specifically recognizes H3R17me2a and H4R3me2a
marks that have been deposited by Carm1 or PRMT1 (Yang
et al., 2010). Notably, the C-terminal forms of MLL1/2 do not
contain a Tudor domain. Therefore, we assessed whether the
C-terminal form of MLL2 recognizes other proteins that are
methylated on arginine by Carm1, CA150, and Pabp1 (Chen
et al., 2002; Lee et al., 2002). We performed an in vitro binding
assay with arginine methylated or unmethylated Pax7-FLAG,
CA150-FLAG, or Pabp1-FLAG, and in vitro synthesizedMLL2(c).
Notably, we found that the C-terminal form of MLL2 specifically
bound to methylated Pabp1, but not to CA150 (Figures 4E
and S4G–S4H). Taken together, these data indicate that the
C-terminal form of MLL2 contains a binding module that specif-
ically mediates interactions with a subset of proteins that are
methylated on arginine residues.338 Cell Stem Cell 11, 333–345, September 7, 2012 ª2012 Elsevier IMethylation of Pax7 Is Required for H3K4me3
Enrichment and Recruitment ofMLL by Pax7 to theMyf5
Promoter
Our experiments establish that Carm1 methylates specific argi-
nines in the amino-terminal region of Pax7. Once methylated,
Pax7 is then specifically bound byMLL1/2 and the HMT complex
is assembled. To characterize the assembly process on chro-
matin, we examined Carm1-dependent MLL complex recruit-
ment, the H3K4me3 enrichment on Myf5 +0.7 kb and +1.5 kb
regions from transcription start site (TSS), and Pax7 binding on
Myf5 -57.5 kb enhancer region by ChIP-qPCR analysis (Fig-
ure 5A) (McKinnell et al., 2008).
Mock or Pax7 overexpressing Carm1+/ and Carm1/ pri-
mary myoblasts were established by retrovirus infection (Fig-
ure S5A) andMyf5mRNA expression was detected by qRT-PCR
(Figure 5B). As expected, Pax7 overexpression inCarm1+/ cells
revealed a5-fold induction ofMyf5mRNA,whereas this induction
is reduced in Carm1/ cells. Consistent with our observations
thatCarm1does not regulatePax7DNAbinding,we foundsimilar
Pax7 binding in the enhancer region in both cell populations (Fig-
ure 5C). Examining the proximal promoter ofMyf5, the increasednc.
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correlated with Pax7 overexpression in Carm1+/ primary myo-
blasts. By contrast, reduced binding of ASH2L and RBBP5 and
reduced enrichment of H3K4me3 were consistently observed in
Carm1/ primary myoblasts, in spite of Pax7 overexpression
(Figures 5D and 5E).
We next investigated whether arginine methylation of Pax7
was directly required to recruit MLL complex components and
remodel chromatin over the Myf5 gene. Mock, Pax7 WT, and
4RKmutant overexpressing primarymyoblasts were established
by retrovirus infection and analyzed for Carm1 and Pax7 protein
and Myf5 mRNA expression. Pax7 WT and 4RK mutant overex-
pressing primary myoblasts showed a similar extent of Pax7 and
Carm1 protein expression (Figure S5B). However, Pax7 4RK
mutant overexpression resulted in reduced Myf5 induction (Fig-
ure 5F). Even though Pax7 binding at the Myf5 -57.5 kb element
was not affected by the loss of the arginine methylation sites
(Figure 5G), the level of MLL complex recruitment by the 4RK
mutant and accumulation of H3K4me3 on Myf5 was similar to
mock infected primary myoblasts (Figures 5H and 5I). These
data support the idea that arginine methylation of Pax7 by
Carm1 is required for MLL complex recruitment and subsequent
H3K4me3 over the Myf5 promoter.
Carm1 Is Required for Satellite Cell Function In Vivo
To examine the functional role of Carm1 in Pax7-expressing
satellite cells, we used we used Pax7-CreERT2:Carm1flox/+:
R26R-eYFP and Pax7-CreERT2:Carm1flox/flox:R26R-eYFP mice
to conditionally inactivate Carm1. Moreover, simultaneous re-
combination at the R26R-eYFP locus allows us to analyze the
functional capacities of Carm1+/ and Carm1/ satellite cells
by labeling their progeny with eYFP. Tamoxifen was injected
to activate Pax7-CreERT2, which is expressed from the Pax7
promoter, leading to a tissue-specific deletion of Carm1 at P14
to generate mice with Carm1+/YFP+ and Carm1/YFP+ satel-
lite cells. One week later, animals were injured with Cardiotoxin
directly injected into the tibialis anterior (TA) muscle and were
analyzed after 21 days (Figure 6A). Carm1/ mice exhibited
a marked regeneration deficit whereby injured muscles weighed
25% less than the muscles from their heterozygous littermates
(Figure 6B). Upon closer examination, YFP+ myofibers deriving
from Carm1/YFP+ satellite cells had a significantly smaller
minimum ferret diameter compared to those derived from
Carm1+/YFP+ satellite cells (Figures 6C and S6). Moreover,
the number of Pax7+YFP+ satellite cells was also significantly
reduced in Carm1/ mice compared to those in the Carm1+/
mice (Figure 6D). To determine whether Carm1 regulate Myf5
expression in satellite cells, we used fluorescence activated
cell sorting (FACS) to prospectively isolate Carm1+/YFP+ and
Carm1/YFP+ satellite cells from mice that were Tamoxifen
treated at P14. Strikingly, we found that, in vivo,Myf5 expression
is reduced by 65% in Carm1/ satellite cells (Figure 6E). This
further demonstrates the requirement for Carm1 in satellite cells
during regeneration.
Several studies have previously implicated Carm1 in terminal
myogenic differentiation of myoblasts (Chen et al., 2002; Gao
et al., 2010; Rudnicki lab, data not shown). Thus the observed
regeneration deficit could be the result of an inability for
Carm1/YFP+ satellite cells to undergo differentiation. Thus,Cell Swe examined the role of Carm1 in proliferation conditions. Using
low-passage primary myoblasts generated from FACS purified
P21 juvenile Pax7-ZsGreen satellite cells, we perturbed either
Carm1 or Pax7 expression by siRNA and monitored their rate
of proliferation. Similar to siPax7, P21 myoblasts transfected
with siCarm1 showed severe growth deficits (Figure 6F). This
suggests that the reduction in Pax7+YFP+ satellite cells in
Carm1/ muscles after injury is due to a proliferation deficit.
Carm1 Is Required to Activate Myf5 during Asymmetric
Stem Cell Divisions
Arginine methylation of Pax7 by Carm1 is required for Myf5
induction. Therefore, we hypothesized that the de novo activa-
tion of Myf5 transcription that occurs following asymmetric
satellite stem cell division requires MLL complex recruitment
and that this induction is regulated by Carm1-mediated arginine
methylation of Pax7. Satellite stem cells and their daughter
satellite myogenic cells are readily discerned using Myf5-Cre
and R26R-eYFP alleles (Kuang et al., 2007). Satellite stem cells
have never expressed Myf5-Cre and hence do not express
R26R-eYFP. By contrast, satellite myogenic cells have ex-
pressed Myf5-Cre and thus express R26R-eYFP. Satellite stem
cells give rise to satellite myogenic cells through asymmetric
apical-basal cell divisions that are visualized during culture of
isolated myofibers (Kuang et al., 2007).
To analyze the requirement for Carm1 during asymmetric
satellite stem cell divisions, we depleted Carm1 by siRNA knock-
down in satellite cells on single myofibers fromMyf5-Cre:R26R-
eYFP mice. As a control, Pax7 was knocked down in parallel
experiments, to ascertain the requirement for Pax7 for the induc-
tion of Myf5 following asymmetric stem cell division. Strikingly,
we observed that the percentage of asymmetric satellite stem
cell divisions after 42 hr of culture was markedly reduced
following siRNA transfection of siCarm1 or siPax7 (Figure 7A).
We observed that 44% of stem cell divisions were asymmetric
following transfection of scrambled siRNA (Figure 7B). By con-
trast, transfection of siCarm1 significantly reduced the propor-
tion of asymmetric divisions to 8% (p = 0.003). Similarly, trans-
fection of siPax7 reduced the proportion of asymmetric cell
divisions to 10% (p = 0.002). Importantly, the total number of
satellite cells was not changed (Figure S7A) but the overall
proportion of satellite stem cells increased by about 30% (Fig-
ure 7C). Moreover, a similar reduction of asymmetric division in
Pax7 knockdown satellite stem cells was detected by immuno-
staining using anti-CD34, -Pax7, and -YFP antibodies (data not
shown).
Pax7 and Carm1 are both expressed in YFP+ satellite
myogenic cells and YFP satellite stem cells. However, only
YFP+ stem cells have an activeMyf5 promoter. Using a proximity
ligation assay (Duolink), we set out to examine whether Pax7-
Carm1 interactions take place equally in both cell types. Impor-
tantly, we find that Pax7 andCarm1 only interact in the nucleus of
YFP+ satellite myogenic cells (Figures 7E and 7F). By knocking
down Carm1 with siRNA, we lose this interaction completely
(Figure S7B). This correlation between Pax7-Carm1 interactions
and Myf5 expression in satellite cells strongly supports the
hypothesis that Carm1 methylation of Pax7 is required for Myf5
expression and also suggests Carm1 is itself subject to regula-
tion during asymmetric cell division.tem Cell 11, 333–345, September 7, 2012 ª2012 Elsevier Inc. 339
Figure 5. Carm1 Methylation of Pax7 Is Required for H3K4me3 Enrichment and Recruitment of the MLL Complex to the Myf5 Proximal
Promoter
(A) Location of primer sets for ChIP-qPCR analysis of Myf5 promoter. TSS, transcription start site.
(B) RT-qPCR analysis of Myf5 mRNA expression.
Cell Stem Cell
Arginine Methylation Regulates Pax7 Activity
340 Cell Stem Cell 11, 333–345, September 7, 2012 ª2012 Elsevier Inc.
Cell Stem Cell
Arginine Methylation Regulates Pax7 ActivityTaken together, these data demonstrate a critical role for
Carm1 in regulating Pax7 function in muscle stem cells. The
presence of similar levels of Carm1 protein in the nuclei of satel-
lite stem cells and satellite myogenic cells (Figure 7A) suggests
that Carm1 activity is subject to posttranslational regulation.
Therefore, we conclude that the de novo activation ofMyf5 tran-
scription in committed satellite myogenic cells, following an
asymmetric stem cell division, requires Carm1-mediatedmethyl-
ation of Pax7.
DISCUSSION
Molecular mechanisms initiating the transcription of factors
involved in lineage commitment following asymmetric stem cell
divisions have long remained an open question. Our experiments
identify Carm1 as the key factor that activates Pax7 during the
commitment of satellite stem cells. We demonstrate that arginine
methylation of Pax7 is required for MLL1/2 binding and HMT
complex assembly. Moreover, we found that Carm1 binding to
Pax7 is inhibited in satellite stem cells in order to maintain the
stem cell state. Thus, Carm1 methylation of Pax7 functions as
the molecular switch for the epigenetic activation of the myo-
genic determination gene Myf5.
Carm1 is a protein arginine methyltransferase that methylates
histone R17 and 26 and has an activator function that is coupled
with the SWI/SNF chromatin-remodeling complex (Xu et al.,
2004). Histone H3 arginine methylation at R17 and 26 is enriched
on transcriptional active genes and Carm1 regulated genes
are enriched by H3R17me2 and H3R26me2 modifications in
their promoter regions (Ma et al., 2001). We examined Carm1
localization and H3K17me2 enrichment on the -57.5 kb enhancer
and +0.7 kb proximal promoter of Myf5 using ChIP-qPCR
and detected no significant enrichment in Carm1 binding nor
H3K17me2 (data not shown). Therefore, Carm1 methylation of
Pax7 versus that of histones H3 appear to be mechanistically
independent of one another.
Carm1 has recently been demonstrated to regulate the estab-
lishment of cell polarity by changing the apical localization of the
partition defective (Par)-complex to promote asymmetric cell
division in early mouse embryos (Torres-Padilla et al., 2007;
Parfitt and Zernicka-Goetz, 2010). The asymmetric distribution
of the Par-complex has been noted in asymmetric stem cell
divisions in Drosophila, in the vertebrate zygote, and in adult
stem cells (Suzuki and Ohno, 2006). The Par-complex, com-
prised of Par-3/Par-6/atypical protein kinase C (aPKC), par-
ticipates in Numb phosphorylation and the polarized localiza-
tion of phosphorylated Numb (Tajbakhsh et al., 2009). Our(C) DNA binding activity of Pax7 onMyf5 -57.5 kb enhancer in mock or Pax7-FLA
qPCR analysis using anti-Pax7 antibody or FLAG M2 antibody.
(D) ChIP-qPCR analysis of H3K4me3 enrichment.
(E) ChIP-qPCR analysis of MLL complex recruitment.
(F) RT-qPCR analysis of Myf5 mRNA expression in Pax7 WT or 4RK mutant ove
(G) DNA binding activity of Pax7 onMyf5 -57.5 kb enhancer in mock, Pax7-FLAGW
qPCR analysis using anti-Pax7 antibody or -FLAG M2 antibody.
(H) ChIP-qPCR analysis of H3K4me3 enrichment in Pax7 WT or 4RK mutant over
(I) ChIP-qPCR analysis of MLL complex recruitment, in Pax7 WT or 4RK mutant
n = 3, error bars represent SEM, and p values are indicated in individual analysis
See also Figure S5.
Cell Sexperiments indicate that activation of Myf5 transcription in
the apical satellite cell requires Carm1 and Pax7. However,
whether this process is mechanistically downstream of the
Par complex or functions in a parallel manner remains to be
addressed.
Equivalent nuclear expression of Carm1 is observed in both
satellite stem cells and satellite myogenic cells but can only
bind to Pax7 in satellite myogenic cells. Therefore, it is reason-
able to speculate that Carm1 is regulated by posttranslational
modification during satellite stem cell asymmetric cell division.
Several groups have reported that Carm1 is regulated by phos-
phorylation during mitosis (Higashimoto et al., 2007; Feng et al.,
2009). Phosphorylation of Carm1 at Ser217 inhibits arginine
methylation activity by either diminished methyl donor binding
or by promoting cytoplasmic localization. These experiments
raise the possibility that Carm1 is phosphorylated in satellite
stem cells thus inhibiting its activity. Alternatively, the interaction
between Pax7 and Carm1may be regulated during satellite stem
cell asymmetric cell division.
The regeneration deficit observed when Carm1 is inactivated
prior to injury-induced regeneration clear demonstrates the
in vivo requirement of Carm1 in myogenesis. Although it has
been previously reported that Carm1 interacts with Mef2C and
other effectors to regulate terminal differentiation (Chen et al.,
2002; Gao et al., 2010), we observe that quiescent satellite
cells depleted of Carm1 exhibit markedly reduced Myf5 expres-
sion and myoblasts maintained in growth conditions proliferate
poorly when they are transfected with siRNA against Carm1. In
addition, reduced numbers of Pax7+YFP+ satellite cells were
observed in Carm1/ mice after injury. Therefore, we conclude
that Carm1 is required for satellite stem cell activation of Myf5
transcription and hence for myoblast expansion.
Myf5 induction demarcates the entry of satellite stem cells
into the myogenic program. In embryonic myogenesis, Pax3,
Wnt, and Shh signaling pathways have been implicated in
regulating Myf5 transcription (Bajard et al., 2006; Tajbakhsh
et al., 1998; Borycki et al., 1999). However, the signaling path-
ways regulating Myf5 expression in adult myogenesis remains
undefined. Previously, we reported that Pax7 directly binds to
the Myf5 -57.5 kb enhancer and recruits the MLL1/2 complex
to epigenetically regulate Myf5 transcription in adult satellite
cells (McKinnell et al., 2008). We have also identified a role
for noncanonical Wnt7a/Fzd7 signaling through the planar-
cell-polarity pathway to drive symmetric stem cell expansion
(Le Grand et al., 2009). Whether Wnt7a/Fzd7 signaling has a
direct or indirect role in regulating Carm1 activity remains to
be determined.G overexpressing Carm1-deleted primary myoblasts was determined by ChIP-
rexpressing primary myoblasts.
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Figure 6. In Vivo Function of Carm1 in Satellite Cells
(A) Schematic of the conditional knockout model used (upper) and the timeline
used for the regeneration studies (lower).
(B) Relative weight of injured TAmuscles 21 days after Cardiotoxin injury (n = 3
per sample group; error bars represent SEM).
(C) Minimum feret diameter of YFP+ fibers measured from immunostained TA
muscle cross-sections (n > 50 fibers per mouse; 3 biological replicates; error
bars represent SEM).
(D) Number of Pax7+YFP+ satellite cells observed in immunostained TAmuscle
cross-sections (n = 3; error bars represent SEM).
(E) qRT-PCR analysis of freshly sorted Carm1+/YFP+ and Carm1/YFP+
satellite cells normalized to Gapdh expression (n = 3; error bars represent
SEM).
(F) Growth curve of P21 juvenile primary myoblasts transfected with siCrtl,
siCarm1 or siPax7 normalized to 0 hr (n = 3; error bars represent SEM).
See also Figure S6.
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netic regulation of stem cell fate decisions, and the recruitment
of HMTs is highly regulated (Ruthenburg et al., 2007; Lim et al.,
2009). Our study has established a new level of regulation for
the recruitment of HMTs on proximal promoter of transcription-
ally active genes. Our experiments demonstrate that Carm1
methylation of arginines in the amino terminus of Pax7 creates
an interface that is specifically recognized and bound by the
C-terminal cleavage forms of MLL1/2 and subsequently the
MLL HMT complex. This interaction recruits the MLL HMT com-
plex to the proximal promoter sequences of Myf5, leading to its
transcriptional induction.
Recent findings implicate the interaction between histones
and effector proteins through methylation as a crucial step in
the translation of the histone code in influencing downstream
biological processes (Kouzarides, 2007; Yun et al., 2011). PHD
and Tudor royal domain comprising chromo, PWWP, and MBT
domain recognize histone lysine methylation at H3K4, K9, K27,
K36, and H4K20 (Chen et al., 2011). H3R17me2a and H4R3me2a
marks are recognized by a reader domain in TDRD3 (Yang
et al., 2010). Notably, PHD finger in nucleosome remodeling
factor (NURF), an ISWI-containing ATP-dependent chromatin-
remodeling complex, recognizes H3K4me3 and this recognition
is coupled with NURF-mediated ATP-dependent chromatin
remodeling to maintain Hox gene expression patterns during
development (Wysocka et al., 2006).
Protein-protein binding of nonhistone proteins is also medi-
ated by binding of particular domains to methylated sequences
(Bedford and Clarke, 2009; Sims and Reinberg, 2008). For exam-
ple, lysine methylated p53 and arginine methylated CA150
and RNA polII are recognized by the Tudor domains in 53BP1,
SMN, and TDRD3, respectively, to specify interactions and
mediate downstream events (Huang et al., 2007; Cheng et al.,
2007; Sims et al., 2011). Notably, our discovery that the recogni-
tion and binding to arginine methylated Pax7 and Pabp1 by the
C-terminal region of MLL1/2 reveals the existence of a class of
reader module for the specific recognition of arginine methylated
proteins.
Our experiments have defined theC-terminal region ofMLL1/2
as containing a module for the specific recognition of arginine
methylation on Pax7 to effect sequence-specific protein-protein
binding.Moreover, our findingsdemonstrate thatCarm1directed
methylation of Pax7 functions as the molecular switch for
the epigenetic activation of the myogenic determination gene
Myf5 following the asymmetric division of a satellite stem cell.
Together, these experiments provide important insight into the
molecular mechanisms that regulate the specification of stem
cells and the regulation of gene expression during asymmetric
stem cell divisions.
EXPERIMENTAL PROCEDURES
Detail experimental procedures are described in the Supplemental Experi-
mental Procedures.
Cell culture
Primary myoblasts were cultured as previously described (Huang et al., 2007).
For protein expression or siRNA knockdown in primary myoblasts, cells
were infected by retrovirus with polybrene or transfected by Lipofectamine
RNAiMAX reagent (Invitrogen).nc.
Figure 7. Carm1 Regulates Myf5 Induction following Satellite Stem Cell Asymmetric Cell Division
(A) Immunocytochemistry of Pax7, Carm1, and YFP in Ctrl, Carm1, or Pax7 siRNA treatedmuscle fibers isolated fromMyf5-Cre:R26R-eYFPmice and cultured for
42 hr. Satellite stem cells are YFP and satellite myogenic cells are YFP+ Pax7 (green); Carm1 (red), DAPI (blue); YFP (white). Scale bars represent 20 mm.
(B) Increased numbers of satellite stem cells after Carm1 or Pax7 siRNA knockdown (n = 4; error bars represent SEM).
(C) Asymmetric satellite stem cells divisions are markedly decreased following knockdown of Carm1 or Pax7 (n = 4; error bars represent SEM).
(D) Proximity ligation assay against Pax7 and Carm1 (red) counterstained for Sdc4 (green) to demarcate satellite cells; DAPI (blue) and YFP to distinguish satellite
stem cells and myogenic satellite cells (white). Scale bars represent 20 mm.
(E) Quantification of the proximity ligation assay. Duolink+ cells were identified as > five punctate dots in the nucleus (as shown in D; upper) (n = 4; error bars
represent SEM).
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C-terminally 3xFLAG-tagged Pax7, Pax3, Pax6, CA150, Pabp1, GST-Carm1,
and 6xMyc tagged Prmts were expressed in Sf9 cells, BL21-Codon-Plus
(DE3)-RIL cells, or HEK293T cells and purified by affinity purification.
In Vitro Binding Assay
GST fusion protein or FLAG tagged fusion protein was mixed with either the
indicated proteins or nuclear extract in binding buffer.
In Vitro Methyltransferase Assay
The purified methyltransferases were mixed with core histones (Upstate)
or purified substrate proteins in the presence of S-adenylyl [3H]-AdoMet.
[3H]-labeled proteins were resolved by SDS-PAGE and detected by
autoradiography.
In Vivo Labeling of Primary Myoblasts
Mock or Pax7-FLAG overexpressing primary myoblasts were incubated in
the presence of L-[methyl-3H] Methionine. Immunoprecipitated Pax7 was
analyzed by Western blot analysis and autoradiography.Cell SLuciferase Reporter Assay
The indicated plasmidswere transfected into primarymyoblasts or C3H10T1/2
cells with the firefly and renilla luciferase reporters. Reporter activation was
measured by LUMIstar OPTIMA (BMG Labtech) using Dual-Luciferase Re-
porter Assay System (Promega).
Chromatin Immunoprecipitation
The cultured primarymyoblasts were crosslinkedwith either 1% formaldehyde
or 5 mM Dimethyl 3,30-dithiobispropionimidate$2HCl (Thermo). Crosslinked
cells were sheared by Bioruptor (Diagenode) and immunoprecipitated with
the indicated antibodies. Immunoprecipitated DNA was de-crosslinked, re-
covered by phenol/chloroform extraction, and analyzed by quantitative PCR
using CFR384 (Bio-rad).
Mice and Myofiber Experiment
Myf5-Cre:R26R-eYFP mouse was previously described (Kuang et al.,
2007). Single muscle fibers were isolated from the EDL muscle of 6- to 8-
week-old Myf5-Cre:R26R-eYFP mice (SV129) and transfected with siRNA
as described previously (Kuang et al., 2007; Le Grand et al., 2009). Pax7-
CreERT2 homozygote mouse and Carm1flox/floxmouse were crossed to obtaintem Cell 11, 333–345, September 7, 2012 ª2012 Elsevier Inc. 343
Cell Stem Cell
Arginine Methylation Regulates Pax7 ActivityPax7-CreERT2:Carm1+/flox heterozygous (Carm1+/) and Pax7-CreERT2:
Carm1flox/flox homozygous (Carm1/) (Yadav et al., 2003; Nishijo et al.,
2009). Tamoxifen treatment and injury experiments were conducted as de-
scribed previously (Lepper et al., 2009) following the University of Ottawa regu-
lations for animal care and handling.
Immunofluorescence and Proximity Ligation Assay
Immunohistochemistry were conducted as described previously (Kuang et al.,
2007; LeGrand et al., 2009). Duolink (OLink Bioscience) was used according to
manufacturer’s recommendations to visualize the in vivo interaction between
Pax7 and Carm1.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, one table, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2012.07.001.
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